HR and neoplasm: Figure 3b, c indicate that 76.6% of tumor cluster I were HR+/HER2+(Luminal B) and triple-negative tumors while 65.0% of tumor cluster III consisted of the HR+/HER2− (Luminal A) tumors and 25.0% of the HER2+ tumors were found in tumor cluster II.